CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data
Abstract Breast cancer patients with residual disease after neoadjuvant chemotherapy and surgery may benefit from additional anti-cancer therapies. Capecitabine, an oral antimetabolite and prodrug of 5-Flurouracil, has been approved for treating metastatic breast cancer. One randomized clinical tria...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e9264fc7d1f847c1825dcf1a2d935aed |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|